查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015002

醫用視訊內視鏡市場：按產品類型、操作模式、應用和最終用戶分類－2026-2032年全球市場預測

Medical Videoscopes Market by Product Type, Mode Of Operation, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用視訊內視鏡市場價值將達到 189.9 億美元，到 2026 年將成長至 204 億美元，到 2032 年將達到 324.3 億美元，複合年成長率為 7.94%。

主要市場統計數據
基準年 2025 189.9億美元
預計年份：2026年 204億美元
預測年份 2032 324.3億美元
複合年成長率 (%) 7.94%

本策略性入門指南概述了技術進步、臨床期望和營運現實如何相互交織，從而重新定義視訊內視鏡在現代醫療保健中的應用。

目前醫用視訊內視鏡的發展現狀是臨床需求、技術創新和採購要求之間複雜相互作用的結果，直接影響手術室和專科診所。光學技術的進步、感測器的小型化以及數位整合技術的提升，提高了臨床醫生對影像保真度、操作性和一次性工作流程的期望。同時，醫院管理者和供應鏈負責人優先考慮設備的生命週期成本、再處理要求以及與現有影像和記錄系統的互通性。

影像技術的快速發展、臨床實踐向微創醫學的轉變以及採購優先事項的變化，正在重新定義醫療保健系統中視訊內視鏡的應用。

目前，技術、臨床和政策因素的整合正在推動變革，促使視訊內視鏡的設計、採購和使用方式發生根本性改變。首先，成像感測器、LED照明和緊湊型機殼設計等技術的成熟，催生了新一代設備，這些設備在縮小探頭直徑的同時，實現了更高的解析度和更優異的弱光性能。這些技術進步直接轉化為臨床優勢，例如在狹窄的解剖結構中實現更清晰的視野、縮短手術時間以及擴大診斷範圍。

評估 2025 年關稅措施將如何重塑視訊內視鏡產業的供應鏈、採購趨勢和籌資策略，以及由此產生的連鎖營運影響。

美國將於2025年實施的關稅調整將對Videoscope的整個價值鏈產生一系列累積影響，包括採購選擇、定價策略和供應商網路建構。某些醫療設備組件和成品的進口關稅上調，將立即給依賴跨境供應鏈的製造商帶來成本壓力。因此，企業被迫做出策略決策：自行承擔增加的成本、轉嫁給買家，或重組供應鏈網路以降低風險。

從詳細的細分觀點解釋產品設計、操作模式、臨床應用和最終用戶環境如何全面影響設備選擇和採購行為。

細分市場分析揭示了推動整個視訊內視鏡市場採用和採購行為的清晰趨勢，這些趨勢涵蓋產品、操作、應用和最終用戶。根據產品類型，市場可分為軟性視訊內視鏡和剛性視訊內視鏡。軟性視訊內視鏡又可細分為雙通道型（可同時進行器械插入和吸引）和單通道型（針對小直徑手術進行了最佳化）。硬式影像內視鏡包括用於關節可視化的關節鏡系統、用於腹部手術的腹腔鏡器械以及用於精確進入頭頸部解剖結構的耳鼻喉科內視鏡。這些產品之間的差異也體現在設計重點的不同：軟性內視鏡優先考慮操作性和通道配置，而剛性系統則優先考慮結構剛性和整合工作通道。

一項全面的區域分析重點闡述了法律規範、採購慣例和臨床基礎設施的多樣性如何導致世界各地出現不同的部署模式。

區域趨勢不僅影響需求模式，還影響監管策略、供應商企業發展以及跨洲臨床應用軌跡。在美洲，採購慣例往往著重於綜合服務合約、完善的上市後監管以及與醫院集團採購組織的合作。這些因素有利於那些能夠提供可靠的臨床證據、快速回應服務網路以及根據醫療機構預算量身定做的靈活定價結構的供應商。

競爭分析表明，光學技術的創新和卓越的服務，再加上供應鏈的韌性，為市場領導帶來了明顯的競爭優勢。

視訊內視鏡產業的競爭動態體現了產品創新、供應鏈韌性以及支持臨床和營運工作流程能力的綜合作用。主要企業正致力於提升光學性能、人體工學設計以及整合數位平台，以促進影像擷取、標註以及與電子健康記錄的互通性。這些功能提高了臨床醫生的工作效率，並支持醫療機構在文件記錄和品質評估方面實現更廣泛的目標。

為製造商和買家提供可操作的、高優先順序的策略行動，以降低供應風險、增強產品適應性，並使經營模式與臨床價值保持一致。

產業領導企業可以採取多項切實可行的措施，將市場洞察轉化為強大的競爭優勢，同時降低營運和監管風險。首先，應優先考慮模組化產品設計和製造柔軟性，使核心光學平台能夠快速適應不同的通道配置和區域監管要求。這種方法可以減輕單一產品開發流程的負擔，並縮短區域響應型產品的上市時間。

透過結合臨床醫生的見解、監管審查和供應商的技術檢驗，我們透明、多方面的研究途徑能夠產生可追溯的決策見解。

本執行摘要依據的研究整合了第一手和第二手研究資料，包括臨床實踐文獻、監管指南、供應商資訊披露以及結構化專家訪談。第一手資料來源包括與相關專科的臨床醫生、消毒專家和醫院採購經理的討論，旨在了解實際應用中醫療設備的選擇標準和運作限制。這些從業人員的觀點與監管文件和供應商技術規範進行了交叉比對，以檢驗有關醫療設備性能聲明的有效性。

最終的綜合分析強調了透過平衡技術進步、營運韌性和策略採購來維持臨床卓越性的重要性。

總之，內視鏡生態系統正處於技術快速發展與操作複雜性交彙的階段。影像技術和儀器人體工學的進步拓展了臨床應用的可能性，而採購現狀、消毒要求和不斷變化的貿易政策則帶來了新的限制因素，相關人員必須積極應對。這些因素的相互作用迫使供應商不僅要在產品功能方面進行創新，還要在服務交付、供應鏈設計和永續性措施方面進行創新。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用視訊內視鏡市場：依產品類型分類

  • 軟式影像內視鏡
    • 雙通道
    • 單通道
  • 硬式影像內視鏡
    • 關節鏡
    • 腹腔鏡
    • 耳鼻喉科

第9章 醫用視訊內視鏡市場：依操作模式分類

  • 一次性的
  • 可重複使用的

第10章：醫用視訊內視鏡市場：按應用領域分類

  • 耳鼻喉科
  • 胃腸病學
  • 呼吸內科
  • 泌尿系統

第11章 醫用視訊內視鏡市場：依最終用戶分類

  • 日間手術中心
  • 診斷中心
  • 醫院
  • 專科診所

第12章 醫用視訊內視鏡市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫用視訊內視鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 醫用視訊內視鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫用視訊內視鏡市場

第16章：中國醫用視訊內視鏡市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
  • Welch Allyn, Inc.
Product Code: MRR-0363DFE0367A

The Medical Videoscopes Market was valued at USD 18.99 billion in 2025 and is projected to grow to USD 20.40 billion in 2026, with a CAGR of 7.94%, reaching USD 32.43 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 18.99 billion
Estimated Year [2026] USD 20.40 billion
Forecast Year [2032] USD 32.43 billion
CAGR (%) 7.94%

A strategic primer outlining how technological advancement, clinical expectations, and operational realities converge to redefine videoscope utilization in modern care settings

The medical videoscope landscape intersects clinical demand, engineering innovation, and procurement imperatives in ways that directly influence operating suites and specialty clinics. Advances in optics, sensor miniaturization, and digital integration have elevated clinician expectations for image fidelity, maneuverability, and single-use workflows. Meanwhile, hospital administrators and supply chain officers prioritize device lifecycle costs, reprocessing requirements, and interoperability with existing imaging and documentation systems.

As a result, devices originally conceived as niche diagnostic tools now serve as central components of procedural pathways across multiple specialties. This repositioning drives cross-functional decision-making where surgeons, endoscopy nurses, sterile processing teams, and purchasing departments must align on capital planning, device selection, and staff training. Moreover, regulatory scrutiny of reprocessing protocols and infection control further shapes procurement criteria.

Consequently, understanding the interplay between clinical outcomes and operational constraints becomes essential for vendors and health system leaders. This introduction sets the stage for a deeper exploration of transformational shifts, tariff-related pressures, segmentation nuances, regional dynamics, competitive positioning, and actionable recommendations that follow.

How rapid advancements in imaging technology, shifting clinical practice toward minimally invasive care, and evolving procurement priorities are redefining videoscope deployment across healthcare systems

The current landscape is experiencing transformative shifts driven by converging technological, clinical, and policy forces that are reshaping how videoscopes are designed, procured, and utilized. First, technological maturation in imaging sensors, LED illumination, and compact form factors has enabled a new generation of devices that offer higher resolution and improved low-light performance while reducing probe diameter. These engineering advances translate directly into clinical benefits such as improved visualization in narrow anatomy, reduced procedure time, and expanded diagnostic reach.

In parallel, clinical practice patterns are shifting toward minimally invasive procedures and outpatient care pathways, prompting demand for devices that deliver consistent performance in ambulatory surgery centers as well as hospital operating rooms. Additionally, infection prevention priorities and the practicalities of sterile processing have accelerated interest in single-use and hybrid device strategies. This trend affects not only purchasing cycles but also capital budgeting and staff competency requirements.

At the policy level, evolving reimbursement frameworks and procurement guidelines are increasingly emphasizing value-based outcomes, which heighten scrutiny on total cost of care rather than upfront device price alone. Collectively, these shifts compel manufacturers to innovate not only in product features but also in service models, warranty offerings, and lifecycle support. Consequently, stakeholders must reassess supplier partnerships, clinical training programs, and inventory strategies to remain aligned with these transformative currents.

Assessment of how 2025 tariff measures have reshaped supply chains, procurement dynamics, and sourcing strategies across the videoscope industry with cascading operational implications

Tariff adjustments introduced in the United States in 2025 exert a series of cumulative effects across the videoscope value chain, influencing sourcing choices, pricing strategies, and supplier network architecture. Increased import duties on specific medical device components or finished products create immediate cost pressure for manufacturers that rely on cross-border supply chains. As a result, firms face strategic decisions about whether to absorb cost increases, pass them through to buyers, or reconfigure supply networks to mitigate exposure.

In response, many global suppliers accelerate nearshoring, diversify contract manufacturing, or shift component sourcing toward economies with preferential trade arrangements. These adaptations reduce single-source risk but also introduce transition costs such as qualification testing, tooling investment, and regulatory submissions for products manufactured in new facilities. Consequently, lead times may lengthen initially while companies stabilize alternative suppliers and validate production quality.

Procurement teams and clinical leaders experience secondary impacts as hospitals and surgical centers reassess procurement cycles and budgets. Contract renegotiations become more frequent as buyers seek price protection clauses, currency adjustment mechanisms, or supplier commitments on cost containment. Meanwhile, reimbursement and purchasing committees place greater emphasis on product total-cost-of-ownership analyses that account for potential tariff-driven volatility.

Finally, regulatory and compliance teams contend with documentation updates and potential changes to component provenance declarations. In sum, the cumulative impact of tariff measures in 2025 catalyzes a strategic reorientation across the ecosystem: suppliers redesign supply chains for resilience, buyers tighten contractual safeguards, and clinical stakeholders collaborate more closely with procurement to ensure continuity of care with minimal disruption.

In-depth segmentation perspective explaining how product design, operational mode, clinical application, and end-user settings collectively influence device selection and procurement behavior

Segmentation analysis reveals distinct product, operation, application, and end-user dynamics that drive adoption and procurement behavior across the videoscope space. Based on product type, the market divides between flexible and rigid videoscopes; flexible models split further into dual-channel instruments that support simultaneous instrument passage and suction, and single-channel variants optimized for smaller-diameter navigation. Rigid videoscopes encompass arthroscopy systems for joint visualization, laparoscopy instruments tailored to abdominal procedures, and otolaryngology scopes designed for precise access to head and neck anatomy. These product distinctions translate into divergent design priorities: maneuverability and channel configuration for flexible scopes, and structural rigidity and integrated working channels for rigid systems.

Based on mode of operation, devices are categorized as disposable or reusable, a segmentation that directly affects sterile processing workflows, inventory turnover, and environmental considerations. Disposable devices can simplify logistics and reduce reprocessing risk, while reusable systems often require investments in cleaning, inspection, and repair programs. The operational choice between single-use and reprocessable instruments therefore influences procurement cycles, training requirements, and lifecycle cost conversations.

Based on application, clinical domains such as ENT, gastroenterology, pulmonology, and urology each impose unique performance criteria. ENT procedures demand fine optics and slender profiles for narrow anatomy; gastroenterology emphasizes longer insertion lengths and advanced imaging modes for mucosal assessment; pulmonology requires flexible navigation to distal airways alongside robust suction and sampling capabilities; and urology privileges endoluminal access and compatibility with adjunctive instruments. These application-specific needs drive both feature development and tailored service offerings.

Based on end user, ambulatory surgery centers, diagnostic centers, hospitals, and specialty clinics present varying purchasing frameworks and operational constraints. Ambulatory surgery centers typically favor devices that support fast turnover and predictable costs, diagnostic centers focus on throughput and image quality for high-volume procedures, hospitals balance capital equipment stewardship with multi-specialty use, and specialty clinics prioritize devices that align with focused clinical protocols. Together, these segmentation lenses inform product roadmaps, go-to-market strategies, and the design of training and after-sales support.

Comprehensive regional analysis highlighting how variable regulatory frameworks, procurement practices, and clinical infrastructures drive differentiated adoption patterns across global territories

Regional dynamics shape not only demand patterns but also regulatory strategy, supplier footprints, and clinical adoption curves across the continents. In the Americas, procurement practices often emphasize integrated service contracts, strong post-market surveillance, and alignment with hospital group purchasing organizations. These factors favor suppliers that can demonstrate robust clinical evidence, responsive service networks, and flexible pricing structures aligned to institutional budgets.

Across Europe, the Middle East & Africa, regulatory harmonization initiatives and diverse payer models create a complex adoption ecosystem. In some jurisdictions, centralized procurement and stringent device evaluation frameworks accelerate the uptake of devices that clearly demonstrate improved clinical outcomes and cost-effective sterilization pathways. Elsewhere, fragmented purchasing and variable reimbursement models require suppliers to deploy localized commercial strategies and targeted educational outreach.

In the Asia-Pacific region, rapid expansion of ambulatory care facilities, investments in minimally invasive surgery training, and rising domestic manufacturing capabilities alter competitive dynamics. Local regulatory pathways and government procurement priorities can advantage regional manufacturers, while international suppliers adapt through partnerships, local manufacturing, or tailored product portfolios. Across all regions, infrastructure maturity, clinical training availability, and supply chain resilience remain critical determinants of adoption velocity and device lifecycle management.

Analysis of competitive strengths showing how innovation in optics and service excellence combine with supply chain resilience to create demonstrable advantages for market leaders

Competitive dynamics in the videoscope sector reflect a combination of product innovation, supply chain resilience, and the ability to support clinical and operational workflows. Leading companies invest in optical performance, ergonomic design, and integrated digital platforms that facilitate image capture, annotation, and interoperability with electronic health records. These capabilities enhance clinician efficiency and support broader institutional objectives for documentation and quality measurement.

Manufacturers that pair compelling hardware with robust service models-such as rapid parts replacement, remote diagnostics, and training programs-tend to capture stronger loyalty among hospital systems. Strategic partnerships with contract manufacturers and localized assembly facilities also enable quicker response to shifts in demand and regulatory requirements. In addition, companies that proactively address single-use device sustainability concerns by offering recycling programs or lifecycle assessments gain traction among environmentally conscious purchasers.

Moreover, firms that demonstrate transparent supply chain practices and proactive tariff mitigation strategies are better positioned during periods of policy-induced volatility. Investors and strategic buyers seek companies with diversified revenue streams, established clinical validation, and clear roadmaps for addressing emerging infection control and data integration requirements. Overall, competitive advantage accrues to organizations that harmonize product excellence with operational support and supply chain foresight.

Practical, high-priority strategic actions for manufacturers and purchasers that reduce supply risk, enhance product adaptability, and align commercial models with clinical value

Industry leaders can take several actionable steps to convert market insights into durable advantage while mitigating operational and regulatory risks. First, prioritize modular product design and manufacturing flexibility so that core optical platforms can be quickly adapted to different channel configurations or regional regulatory requirements. This approach reduces the burden of separate product development streams and accelerates time-to-market for localized variants.

Second, develop a diversified supplier base and qualify alternate contract manufacturers proactively to reduce exposure to tariff shocks and logistics disruptions. Complement that strategy with clear provenance documentation and serial-tracking capabilities to facilitate regulatory compliance and recall readiness. Third, strengthen commercial value propositions by bundling devices with training, service guarantees, and data integration tools that help procurement committees evaluate total cost and clinical benefit more holistically.

Fourth, establish sustainability initiatives that address single-use device waste through take-back programs, recyclable materials, or validated reprocessing partnerships where clinically appropriate. Fifth, engage in proactive dialogue with payers and hospital administration to align device evaluation with outcome measures that matter for reimbursement and purchasing decisions. By implementing these steps in concert, companies can enhance resilience, deepen clinical partnerships, and create more defensible positions in competitive tenders.

Transparent multi-method research approach combining clinician insights, regulatory review, and supplier technical validation to produce decision-ready findings with traceable provenance

The research synthesis underlying this executive summary integrates primary and secondary evidence, combining clinical practice literature, regulatory guidance, supplier disclosures, and structured expert interviews. Primary inputs included discussions with practicing clinicians across relevant specialties, sterile processing experts, and hospital procurement leaders to capture real-world device selection criteria and operational constraints. These practitioner perspectives were cross-referenced with regulatory documentation and supplier technical specifications to validate device capability claims.

Secondary sources comprised peer-reviewed clinical studies, guidance documents from regulatory authorities, and public filings that shed light on device performance, safety considerations, and post-market surveillance outcomes. Analytical steps included triangulating qualitative insights with supplier declarations to identify recurring themes around durability, ergonomics, and sterilization compatibility. The methodology also incorporated scenario analysis to explore supply chain responses to policy changes and to surface pragmatic mitigation strategies for stakeholders.

Throughout, the approach emphasized transparency and traceability: sources were evaluated for recency and relevance, and divergent perspectives were highlighted to ensure balanced conclusions. This multi-method approach supports robust, decision-ready insights while acknowledging areas where further empirical research or targeted field validation would strengthen specific findings.

Final synthesis emphasizing the imperative to balance technological advancement with operational resilience and strategic procurement to sustain clinical excellence

In conclusion, the videoscope ecosystem stands at a nexus of rapid technological progress and operational complexity. Advances in imaging and device ergonomics are expanding clinical possibilities, while procurement realities, sterilization imperatives, and evolving trade policies impose new constraints that stakeholders must actively manage. The interplay of these forces encourages suppliers to innovate not only in product features but also in service delivery, supply chain design, and sustainability initiatives.

For clinical leaders and procurement officers, the challenge is to align device selection with broader institutional objectives-balancing clinical efficacy, operational efficiency, and fiscal prudence. For manufacturers, the imperative is to deliver adaptable platforms, transparent supply practices, and compelling post-sale support that demonstrably reduce total cost and clinical risk. Ultimately, organizations that integrate technological excellence with resilient operational strategies will be best positioned to meet clinician needs and support high-quality patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Videoscopes Market, by Product Type

  • 8.1. Flexible Videoscopes
    • 8.1.1. Dual Channel
    • 8.1.2. Single Channel
  • 8.2. Rigid Videoscopes
    • 8.2.1. Arthroscopy
    • 8.2.2. Laparoscopy
    • 8.2.3. Otolaryngology

9. Medical Videoscopes Market, by Mode Of Operation

  • 9.1. Disposable
  • 9.2. Reusable

10. Medical Videoscopes Market, by Application

  • 10.1. ENT
  • 10.2. Gastroenterology
  • 10.3. Pulmonology
  • 10.4. Urology

11. Medical Videoscopes Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Medical Videoscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Videoscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Videoscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Videoscopes Market

16. China Medical Videoscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Boston Scientific Corporation
  • 17.7. CONMED Corporation
  • 17.8. FUJIFILM Holdings Corporation
  • 17.9. HOYA Corporation
  • 17.10. KARL STORZ SE & Co. KG
  • 17.11. Medtronic plc
  • 17.12. Olympus Corporation
  • 17.13. Richard Wolf GmbH
  • 17.14. Smith & Nephew plc
  • 17.15. Stryker Corporation
  • 17.16. Welch Allyn, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL VIDEOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL VIDEOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 127. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 128. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 148. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 149. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)